These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26654731)

  • 1. Probabilistic Measurement of Central Line-Associated Bloodstream Infections.
    Hota B; Malpiedi P; Fridkin SK; Martin J; Trick W
    Infect Control Hosp Epidemiol; 2016 Feb; 37(2):149-55. PubMed ID: 26654731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of revising the National Nosocomial Infection Surveillance System definition for catheter-related bloodstream infection in ICU: reproducibility of the National Healthcare Safety Network case definition in an Australian cohort of infection control professionals.
    Worth LJ; Brett J; Bull AL; McBryde ES; Russo PL; Richards MJ
    Am J Infect Control; 2009 Oct; 37(8):643-8. PubMed ID: 19589619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for central line-associated bloodstream infection in pediatric intensive care units.
    Wylie MC; Graham DA; Potter-Bynoe G; Kleinman ME; Randolph AG; Costello JM; Sandora TJ
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1049-56. PubMed ID: 20731595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective, Holistic, Multicenter Approach to Tracking and Understanding Bloodstream Infections in Pediatric Hematology-Oncology Patients.
    Gaur AH; Bundy DG; Werner EJ; Hord JD; Miller MR; Tang L; Lawlor JP; Billett AL;
    Infect Control Hosp Epidemiol; 2017 Jun; 38(6):690-696. PubMed ID: 28399945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statewide validation of hospital-reported central line-associated bloodstream infections: Oregon, 2009.
    Oh JY; Cunningham MC; Beldavs ZG; Tujo J; Moore SW; Thomas AR; Cieslak PR
    Infect Control Hosp Epidemiol; 2012 May; 33(5):439-45. PubMed ID: 22476268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating application of the National Healthcare Safety Network central line-associated bloodstream infection surveillance definition: a survey of pediatric intensive care and hematology/oncology units.
    Gaur AH; Miller MR; Gao C; Rosenberg C; Morrell GC; Coffin SE; Huskins WC
    Infect Control Hosp Epidemiol; 2013 Jul; 34(7):663-70. PubMed ID: 23739069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates.
    Lin MY; Hota B; Khan YM; Woeltje KF; Borlawsky TB; Doherty JA; Stevenson KB; Weinstein RA; Trick WE;
    JAMA; 2010 Nov; 304(18):2035-41. PubMed ID: 21063013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The descriptive epidemiology of central line-associated bloodstream infection among patients in non-intensive care unit settings.
    Tedja R; Gordon SM; Fatica C; Fraser TG
    Infect Control Hosp Epidemiol; 2014 Feb; 35(2):164-8. PubMed ID: 24442079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a modified surveillance definition of central line-associated bloodstream infections for patients with hematologic malignancies.
    Digiorgio MJ; Fatica C; Oden M; Bolwell B; Sekeres M; Kalaycio M; Akins P; Shane C; Bako J; Gordon SM; Fraser TG
    Infect Control Hosp Epidemiol; 2012 Sep; 33(9):865-8. PubMed ID: 22869258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State health department validations of central line-associated bloodstream infection events reported via the National Healthcare Safety Network.
    Bagchi S; Watkins J; Pollock DA; Edwards JR; Allen-Bridson K
    Am J Infect Control; 2018 Nov; 46(11):1290-1295. PubMed ID: 29903420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of 2015 NHSN Catheter-associated Urinary Tract Infection (CAUTI) Definition Change on Central Line-associated Bloodstream Infection (CLABSI) Rates and CLABSI Prevention Efforts at an Academic Medical Center.
    Advani SD; Lee RA; Long M; Schmitz M; Camins BC
    Infect Control Hosp Epidemiol; 2018 Jul; 39(7):878-880. PubMed ID: 29665877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the impact of mandatory public reporting on participation and performance in a program to reduce central line-associated bloodstream infections: evidence from a national patient safety collaborative.
    Marsteller JA; Hsu YJ; Weeks K
    Am J Infect Control; 2014 Oct; 42(10 Suppl):S209-15. PubMed ID: 25239712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition.
    See I; Iwamoto M; Allen-Bridson K; Horan T; Magill SS; Thompson ND
    Infect Control Hosp Epidemiol; 2013 Aug; 34(8):769-76. PubMed ID: 23838215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central line-associated bloodstream infections in non-ICU inpatient wards: a 2-year analysis.
    Rhee Y; Heung M; Chen B; Chenoweth CE
    Infect Control Hosp Epidemiol; 2015 Apr; 36(4):424-30. PubMed ID: 25782897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of statewide surveillance system data on central line-associated bloodstream infection in intensive care units in Australia.
    McBryde ES; Brett J; Russo PL; Worth LJ; Bull AL; Richards MJ
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1045-9. PubMed ID: 19803720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electronic surveillance for healthcare-associated central line-associated bloodstream infections outside the intensive care unit.
    Woeltje KF; McMullen KM; Butler AM; Goris AJ; Doherty JA
    Infect Control Hosp Epidemiol; 2011 Nov; 32(11):1086-90. PubMed ID: 22011535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Mar; 60(8):243-8. PubMed ID: 21368740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central line-associated bloodstream infection rate elevation: Attributable to National Healthcare Safety Network surveillance definition changes, ongoing opportunities for infection prevention, or both?
    Corley A; Cantara M; Gardner J; Trexler P; Rock C; Maragakis LL
    Am J Infect Control; 2017 Sep; 45(9):1030-1032. PubMed ID: 28736032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Device-associated nosocomial infection rates in intensive care units at Cairo University hospitals: first step toward initiating surveillance programs in a resource-limited country.
    El-Kholy A; Saied T; Gaber M; Younan MA; Haleim MM; El-Sayed H; El-Karaksy H; Bazara'a H; Talaat M
    Am J Infect Control; 2012 Aug; 40(6):e216-20. PubMed ID: 22418610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causative Organisms and Associated Antimicrobial Resistance in Healthcare-Associated, Central Line-Associated Bloodstream Infections From Oncology Settings, 2009-2012.
    See I; Freifeld AG; Magill SS
    Clin Infect Dis; 2016 May; 62(10):1203-9. PubMed ID: 26936664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.